- Assay duration:Multiple steps
- Assay Type:Sandwich
- Conjugate ELISA:Biotin
- Format:Pre-coated
- Host:Rabbit
- Primary antibody reactivity:Mouse
- Target protein:FSTL3
- Size:1 kit
- Sample Type:Serum, plasma and other biological fluids
- Cross Reactivity:No significant cross-reactivity or interference between Follistatin Like Protein 3 (FSTL3) and analogues was observed
- Detection Method:Colorimetric
- Time to Results:3 h
- Shelf Life:12 Months
- Detection Range:15.6 - 1000 pg/ml
- Storage Temperature:4 °C for one month (frequent use), −20 °C for one year
- Sample Volume:100 µl
- Sensitivity:6.4 pg/ml
- Regulatory Status:RUO
- Cat. No.:MSPP-SEJ084MU
- No. of tests:96 wells
This assay has high sensitivity and excellent specificity for detecting Mouse FSTL3 (Follistatin Like Protein 3). The assay range is from 15.6 to 1000 pg/ml (Sandwich kit) with a sensitivity of 6.4 pg/ml. There is no detectable cross-reactivity with other relevant proteins. Activity loss rate and accelerated stability test ect have been conducted to guarantee the best performance of the products after long storage and delivery.
- High sensitivity and specificity
- Perfect reproducibility and consistency across batches
- Quality control with three-level inspections
- Wide range of targets/species available
- Intra-assay: CV<10%; Inter-assay: CV<12%
Follistatin-like 3 is a secreted glycoprotein of the follistatin-module-protein family. It may have a role in leukemogenesis.The FSTL3 cDNA, which they called FLRG (follistatin-related gene), encodes a deduced 263-amino acid protein that shares 85% amino acid identity with mouse Fstl3. It contains 2 cysteine-rich repeats that are closely related to the class 1-1 follistatin modules present in other follistatin family members. Northern blot analysis demonstrated expression of a 2.5-kb transcript in placenta, amniocytes, chorionic villosities, and bone marrow stromal cells, with weaker expression in fibroblasts, keratinocytes, and endothelial cells. A 1.3-kb transcript was also detected in some human tissues and was thought to result from use of an alternate polyadenylation site.